1
Thomas Kissel, Armin Breitenbach, Tobias Jung, Walter Kamm: Self-assembling colloidal carriers for protein delivery. Medinnova Gesellschaft fur Medizinsche Innovationen aus Adkademischer Forschung mbH, Foley & Lardner, September 9, 2003: US06616944 (10 worldwide citation)

The invention is directed to self-assembling, polymer-based delivery systems for proteins. The delivery systems comprises an active agent and a polyol ester of the invention, having a linear polyol containing six or more hydroxyl groups as a central backbone and biodegradable hydroxy carboxylic este ...


2
Armin Breitenbach, Hans Michael Wolff: Hot-melt TTS for administering rotigotine. UCB Pharma, Harness Dickey & Pierce, July 3, 2012: US08211462 (3 worldwide citation)

This patent application relates to a transdermal therapeutic system (TTS) that comprises a Rotigotine-containing cement layer, characterized in that the cement layer contains a hot-meltable adhesive in which Rotigotine as the active substance is dispersed and partly or completely dissolved. The pate ...


3
Armin Breitenbach: Device for the transdermal administration of a rotigotine base. UCB Pharma, Harness Dickey & Pierce, October 1, 2013: US08545872 (2 worldwide citation)

The invention relates to a polymer matrix suitable for the transdermal administration of rotigotine [(−)-5, 6, 7, 8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphtol], containing a matrix for the transdermal administration of rotigotine [(−)-5, 6, 7, 8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl] ...


4
Armin Breitenbach, Claus Meese, Hans Michael Wolff, Roland Drews: Transdermal administration of (R)-3,3-diphenylpropylamin-monoesters. Schwarz Pharma, Kenyon & Kenyon, March 2, 2010: US07670621 (1 worldwide citation)

The invention relates to a device for transdermally administering a compound of formula (I), wherein A represents hydrogen or deuterium, R represents a group selected among C1-4alkyl, C3-10cycloalkyl, or phenyl, each of which can be substituted by C1-3alkoxy, fluoride, chlorine, bromine, iodine, nit ...


5
Armin Breitenbach, Hans Michael Wolff: Hot melt TTS for administering rotigotine. UCB PHARMA, Harness Dickey & Pierce, November 17, 2015: US09186335

The invention relates to a transdermal therapeutic system (TTS) which contains a rotigotine-containing adhesive layer and is characterized by the fact that the adhesive layer contains a hot-meltable contact adhesive. The invention also relates to the use of rotigotine for producing the adhesive laye ...


6
Armin Breitenbach, Claus Meese, Hans Michael Wolff, Roland Drews: High purity bases of 3,3-diphenylpropylamino monoesters. UCB Pharma, Kenyon & Kenyon, August 2, 2011: US07989654

The invention relates to a compound of general formula (I) wherein A represents deuterium or hydrogen, R represents a group selected from C1-6 alkyl, C3-10 cycloalkyl or phenyl, which can be substituted by C1-3 alkoxy, fluorine, chlorine, bromine, iodine, nitro, amino, hydroxyl, oxo, mercapto or deu ...


7
Christian Leichs, Armin Breitenbach, Ingo Lehrke, Paolo Galfetti: Non-mucoadhesive film dosage forms. Labtec, APR Applied Pharma Research, Clark G Sullivan, Troutman Sanders, November 12, 2013: US08580830

Orally disintegrating film dosage forms for delivering active pharmaceutical agents, methods of formulating the dosage forms to retard absorption through the oral mucosa, and methods of using the dosage forms for the treatment of various medical conditions are provided.


8
Armin Breitenbach, Claus Meese, Hans Michael Wolff, Roland Drews: Transdermal delivery of (R)-3,3-diphenylpropylamin-monoestern. UCB Pharma, Kenyon & Kenyon, April 5, 2011: US07919117

The invention relates to a device for transdermally administering a compound of formula (I), wherein A represents hydrogen or deuterium, R represents a group selected among C1-4alkyl, C3-10cycloalkyl, or phenyl, each of which can be substituted by C1-3alkoxy, fluoride, chlorine, bromine, iodine, nit ...


9
Sebastian Braun, Armin Breitenbach, Ralf Schliephacke: Method for producing and monitoring oral active ingredient films. TESA SE, TESA LABTEC, Norris McLaughlin & Marcus PA, January 10, 2017: US09539206

Method for producing and monitoring oral active ingredient films with a base to which a solution containing at least one active ingredient is applied, the method comprising the steps: • metering and mixing the base formulation, • coating the base formulation onto a substrate, so that a strip results ...


10
Armin Breitenbach, Hans Michael Wolff: Hot-melt TTS for administering Rotigotine. Edwards & Angell, July 15, 2004: US20040137045-A1

This patent application relates to a transdermal therapeutic system (TTS) that comprises a Rotigotine-containing cement layer, characterized in that the cement layer contains a hot-meltable adhesive in which Rotigotine as the active substance is dispersed and partly or completely dissolved. The pate ...